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ABSTRACT
A user-friendly, advanced software package for
gene design is described. The software comprises
an integrated suite of programs—also provided as
stand-alone tools—that automatically performs the
following tasks in gene design: restriction site predic-
tion, codon optimization for any expression host,
restriction site inclusion and exclusion, separation
of long sequences into synthesizable fragments,
Tm and stem–loop determinations, optimal oligonuc-
leotide component design and design verification/
error-checking. The output is a complete design
report and a list of optimized oligonucleotides to be
prepared for subsequent gene synthesis. The user
interface accommodates both inexperienced and
experienced users. For inexperienced users, explan-
atory notes are provided such that detailed instruc-
tions are not necessary; for experienced users,
a streamlined interface is provided without such
notes. The software has been extensively tested in
the design and successful synthesis of over 400 kb
of genes, many of which exceeded 5 kb in length.
INTRODUCTION
To facilitate the emerging field of synthetic biology, the ability
to efficiently synthesize long, accurate DNA sequences is
becoming increasingly important. Rather than accept the
increasing error frequency inevitable in single-step synthesis
of long DNA sequences, we developed automated technology
to synthesize large numbers of perfect 500–800 bp segments,
termed synthons, from PCR assembly of short oligonucleo-
tides together with efficient methods for cloning and connect-
ing them into larger sequences of 5000 bases (1); these are
then joined by conventional manual methods into sequences of
ever-increasing size. Thus far, we reported the synthesis of a
contiguous 32 kb gene cluster, but there is no theoretical upper
size limit for preparing DNA by this approach.
Concomitant with developing gene-synthesis technology,
we required computational software to optimize codons for
expression, incorporate or eliminate restriction sites to allow
modular exchange of segments, design the oligonucleotide
(oligo) components and perform other operations integral to
the synthetic procedure. Although several gene design pro-
grams were either available (2,3) or described (4,5), they
were not appropriate for very long genes and did not contain
all features required for our purpose. We, therefore, developed
a new software package that automates codon optimization,
restriction site placement, separation into synthons and design
of oligo components (Figures 1 and 2). In the process, we
expanded the flexibility of the software by modularizing
and generalizing algorithms to be multi-purpose and included
numerous user-defined parameters to control features of
the software. The result described here is a user-friendly,
advanced software package, called Gene Morphing System
(GeMS), which has broad utility in the design of synthetic
genes to be made by PCR assembly of short oligos.
PROGRAMMING
GeMS was written using the freely available open-source pro-
gramming language Python version 2.3. (www.python.org).
The web-based version uses the open-source Apache HTTP
server version 2.0.49 (www.apache.org). DNA annealing tem-
perature calculations are performed using the dan program
(6,7) and stem–loops are detected using the palindrome pro-
gram available in the EMBOSS suite version 2.10.0 (8). Codon
usage tables are derived from the Kazusa Codon Usage Data-
base (www.kazusa.or.jp/codon/). The software uses the codon-
count program (http://www.kazusa.or.jp/codon/countcodon.
html) to report codon distribution. The synthetic genes
described in this article were designed on a 1.0 GHz Intel
Pentium III PC with 512 MB of memory, running the RedHat
8.0 Linux operating system.
RESULTS
The software comprises a suite of integrated tools
that provides an advanced program for gene design
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(http://software.kosan.com/GeMS). The component tools are
also accessible for individual use, as are codon tables and
restriction site lists (Table 1). The software is divided in
four sections: (i) sequence inputs and restriction site design
(ii) parameter definition for oligo design (iii) program execu-
tion and (iv) report generation. The ensuing description fol-
lows the order of operation of GeMS (Figure 2), coupled with
commentary.
The Home page provides a brief overview of the software
features, along with navigation buttons leading to individual
tools and a support page (Supplementary Figures 1S–8S). The
user first selects either a guided or advanced interface. The
guided interface is for inexperienced users and contains
detailed information on how to navigate the software; the
advanced interface omits explanations and allows for rapid
data entry. In either, if the user is willing to accept GeMS
default values, it is necessary to enter parameters in only six
fields, each specified by a red asterisk.
Sequence inputs and restriction site design
Data input. Upon selection of an interface, the user is taken to
the sequence input form. For gene design involving restriction
site manipulations and codon changes, the input is a protein
sequence, either provided directly or translated from an
entered DNA sequence. The software will also accept a
DNA sequence not to be modified and simply design the
oligo components needed for synthesis (see below; Figure 2).
If the user chooses to place an NdeI site (CATATG) at the start
codon, the software automatically places the His codon, CAT,
50 to the ATG start codon. The user is also allowed to
append DNA sequences to the 50 and 30 ends of the gene.
After entries and choosing options, activation opens the appro-
priate window.
Restriction site inclusion and exclusion. For a codon-
optimized gene, the user chooses whether to have restriction
sites automatically spaced along the gene or to manually place
them at specified locations. With average-sized genes, unique
restriction sites can be automatically spaced to allow cassette
mutagenesis with synthetic oligos. We recommend that no
more than 30 unique sites be spaced along a gene, since pur-
ging a large number of undesirable sites from a randomly
optimized sequence is computationally intensive. GeMS pro-
vides a default of 40 – 15 bp separation of sites as a conveni-
ent size for oligo synthesis of cassettes for genes of 1 kb.
The protein sequence is back-translated to all possible
codons and from these, GeMS reports all possible six- and
eight-base palindromic restriction sites in the GeMS library or
entered by the user that are acceptable for inclusion in the
gene. In the automatic mode of assigning sites, the software
selects sites spaced at the designated distances, if possible. If
these are insufficient or unacceptable, the user may add sites
from the available list or remove sites from the automatically
Figure 1. Overview of the synthon design process showing the placement of Type IIs restriction sites and flanking primers. A and B indicate sites of cleavage at
synthon edges by Type IIs enzymes to form cohesive ends for seamless ligations.
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selected sites. The software prevents selected sites in the final
list from being used elsewhere in the gene. A map showing all
possible sites in the sequence is available for viewing the
spacing of sites.
Because it is often necessary to reserve certain restriction
sites for cloning or use in the vector, it is also desirable to be
able to exclude sites from the gene sequence. For this, the
restriction site library is again displayed, and the user may
choose those to exclude from the designed sequence; as
before, a site absent from the library may be defined and
excluded from the gene sequence.
We note that many programs, such as GCG, MacVector
(from Accelrys) and EMBOSS, provide separate tools to
back-translate protein to DNA and to map restriction sites
in the DNA. In GCG, the backtranslate program can translate
protein to an ambiguous DNA sequence, which can be used as
input for the tool called map to produce a list of possible
restriction sites. Similar tools are also available in MacVector.
With this procedure, amino acids having subsets of codons in
different boxes of the codon table (i.e. Leu, Arg and Ser) are
assigned too many codons, and non-existent or ‘phantom’
restriction sites may be predicted that are incompatible with
the protein sequence. Thus, the standard back-translations are
Leu ! YTN, Arg ! MGN and Ser ! WSN, with Y standing
for C or T, and N for A, G, C or T. The DNA sequences YTN
or MGN each refer to eight codons, only six of which code for
Leu or Arg, respectively. Similarly, WSN refers to 16 codons,
only 6 of which code for Ser. By back-translating these amino
acids into codons rather than nucleotide sequences, GeMS
avoids such ‘phantom’ restriction sites.
It is not possible to insert a unique restriction site into or
exclude a site from all sequences: there may exist restriction
sites that cannot be made to be unique with a desired protein
sequence. For example, in one of the sequences that can
encode the tripeptide AlaArgAla, a BssHII site, GCGCGC,
is present at two different positions, beginning at base 1 and
base 3 of the first codon. Neither of these can be present as a
unique site; either both must be inserted or both must be
removed. As a second example, a request to avoid the
sequence TGGATG fails if its encoded dipeptide TrpMet
appears in the protein sequence.
Restriction site design proposal. The software next presents a
proposed plan for the restriction sites to be included in the
designed gene. The user is informed if intended unique sites
are unique and displays a list of the sites that have been
included or excluded, as well as a restriction site map of
the final design. The user may either return to the previous
window and make modifications or approve the design.
Parameter definition for oligonucleotide design
Codon harmonization. After the user approves the restriction
site design, a window is provided for entry of other gene
design and synthesis parameters. The user selects one of
the several codon usage tables of organisms, or provides
one, to be used in codon harmonization of the synthetic
Figure 2. Sequence of operations during the course of automated gene design; a
failure triggers an attempt to redesign the gene with a randomly chosen set of
codons. Asterisks indicate steps that are skipped when designing native DNA
sequences.
Table 1. Stand-alone tools available in the GeMS software package
GeMS software tool Function
DNA–protein
Translation Translates a DNA sequence into a protein
sequence
Reverse complement Reports the reverse complement of a DNA
sequence
Sequence alignment Aligns protein or DNA sequences based
on local similarities
DNA stem–loops Reports inverted repeats in a DNA
sequence
Assign vectors for LBS Assigns vectors to synthons for ligation-
by-selection
Restriction sites
Restriction sites in DNA Reports restriction sites in a DNA sequence
Predict all possible sites
from protein
Reports all possible restriction sites
Automatic spacing of
unique sites
Spaces unique sites over a designed gene
sequence
Exclude sites Excludes restriction sites while preserving
protein sequence
Codon usage
Custom codon table Creates a custom codon preference table
Hybrid codon table Creates a custom codon preference table for
multiple organisms
Codon optimize Optimizes codons in a DNA sequence for a
desired organism
Oligo design
Tm Calculates melting temperature of
complementary DNA sequences
Design 40mers Designs 40mer oligo components of a
DNA sequence
Design 40mers + primers Designs 40mer oligo components of a
DNA sequence with primers
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gene. The codon preference for each amino acid is calculated
as described by Withers-Martinez et al. (5) using the fractional
preference for each codon within the set encoding each amino
acid. The user may delete one or more codons, or provide a
cut-off frequency that eliminates all codons below that value;
the preferences of the remaining codons are then adjusted
proportionately such that the sum of codon preferences for
each amino acid again equals 1.0.
The software provides a stand-alone tool for creating codon
preference tables weighted for codon usage in multiple organ-
isms, and several of the most useful hybrid tables are provided
as selectable options. When using the tool to construct other
such tables, the user deletes codons considered particularly
undesirable for any of the organisms and the software readjusts
the preferences in each table. The user then enters the weight-
ing factor desired for codons of each organism and calculates








WFið Þ ¼ 1, and WFi > 0 for each i,
where WFi is the weighting factor and Pi is the codon pref-
erence for the individual organism. The software multiplies
codons of each amino acid by the provided factors, sums the
weighted preferences for each codon and creates a multi-
organism preference table to be used in the gene design.
Assembly design. If specified, the software will separate long
coding sequences into smaller fragments or synthons to be
synthesized (1), which then need to be ligated together
(Figure 1). In one approach, the gene is separated into synthons
by size or by number. If the user chooses this approach, the 30
and 50 edges of synthons to be joined will be automatically
designed to overlap by 6 bp when cut to allow compatible cut
sites produced by Type IIs enzymes placed outside of and
adjacent to the synthon ends (Figure 1). The [BsaI] and
[BbsI + G] sites are positioned adjacent to the synthon to
result in cutting the 6 bp synthon edge sequences between
positions 1/2 and 5/6, leaving 4 bp complementary overhangs
that can be ligated to give a seamless connection. In the second
approach, the gene is separated at unique restriction sites cho-
sen by the user, and the software places the chosen sites at the
appropriate 30 and 50 ends of the synthons to be ligated.
If the Type IIs sites are used to connect multiple synthons,
we recommend using ligation-by-selection (1,9). Here, syn-
thons are made in two specialized vectors that each possesses a
unique pair of selectable markers. The vectors are cleaved and
re-ligated to regenerate a vector containing the ligated syn-
thons and a different unique pair of selectable markers. The
2-synthon products of two such ligations can be likewise con-
nected to four, and so on, such that multiple ligations can be
performed without isolating intermediate fragments. A stand-
alone tool is provided that supports synthon cloning and assem-
bly by ligation-by-selection. GeMS calculates the identifying
number for each of the two vectors needed, assigns them to the
appropriate synthon, and generates the plan for ligation steps in
the form of a dendrogram (1). The dendrogram may also be
used as an input to a robot to automate the ligation process.
Flanking sequences. The user enters sequences to be used to
flank each synthon, which are not to be modified by the soft-
ware. These are placed 50 of the Type IIs sites adjacent to the
synthon and are used to construct PCR primer sites, cloning
sites, etc. If Type IIs sites are not used, the sequences are
directly fused to the synthon.
Oligonucleotide design. The user specifies, or accepts by
default, a ‘specificity threshold’ (as described below) and
the number of attempts the software will make to achieve
that parameter. The software will create 40mer oligo compon-
ents of synthons with 20 bp overlaps, with the exception of the
50 oligos of each strand, which can range from 20 to 40 bases.
Then, each 20 base overlap is scanned against both strands;
oligos that have exact 30 complements of the specified number
of bases are analyzed for complementarity over the entire
20 bp. If any inappropriate 20mer overlap has greater than
the user-designated percent complementarity, attempts will be
made to correct the design; if unsuccessful, the entire synthon
will be discarded and the codon randomization repeated.
Tm and stem–loop structure reports. The user may test the
annealing temperature of each half-oligo using the nearest-
neighbor model described by Breslauer (6,7). If an oligo
falls outside a user-defined range, GeMS reports the oligos
in the synthon that failed the Tm parameter for the synthon. The
user may also choose to calculate stem–loop structures and
report those sequences that fail to meet the criteria; however,
the specificity threshold used in design of oligos effectively
prevents most such structures. If all attempts fail to meet the
specified Tm and stem–loop criteria, the user may choose to use
one of the designs, reduce stringency of the failed parameters
or increase the number of attempts at codon randomization.
Program execution
Codon harmonization. After choice of a codon table, a pool of
codons is created for each amino acid that is equal to the
number found in the protein, and that is in accord with
their occurrence in the adjusted codon preference table. The
software randomly shuffles the pool, randomly selects one of
the designated codons and replaces the first natural codon of
the open reading frame with it; the process is repeated sequen-
tially to the C-terminus of the protein to complete optimization
of the synthetic gene. The optimized gene thus contains
codons in the exact proportions in which they are found in
the adjusted codon preference table.
Restriction site placement. The software next eliminates all
restriction sites and sequences entered in the user-specified
removal list from the codon-optimized DNA sequence without
changing the amino acid sequence. In the first pass, the pro-
gram reports occurrences of all restriction sites, their positions
and frames. In the second pass, the program moves to each
location and attempts to eliminate the site by replacing one of
the involved codons with an alternative. If the software
encounters a single-codon amino acid, Met or Trp, an adjacent
codon contained within the restriction site is modified; for
example, with NdeI, the CAT of the hexanucleotide CATATG
is replaced by an alternative His codon, leaving the ATG to
encode Met. The codon preference is altered minimally by
‘fixing’ codons in this way. The user has the option of
3014 Nucleic Acids Research, 2005, Vol. 33, No. 9
checking the altered codon preference by using the codon-
count program.
Because removal of one site can, by coincidence, create
another, the program re-analyzes the purged sequence for
undesired sites. If such sites cannot be eliminated, the program
can enter long loops and this phase of the design process is
aborted; the program discards the initially constructed DNA
sequence, chooses an entirely independent set of codons and
re-attempts the design. After a user-designated number of
tries, the failures along with the offending restriction site
and location are reported and the program terminates. The
user can chose to discard the offending restriction site.
The program then inserts the previously designated restric-
tion sites at the selected locations. For each site, the insertion
algorithm replaces the bases at the appropriate position with
the designated recognition sequence. If a codon for Leu, Arg
or Ser—codons that fall in two different blocks of the codon
table—is interrupted by a site that changes the encoded amino
acid, the program attempts to alter the remainder of the
codon to preserve the amino acid. The program then attempts
to detect and correct undesired restriction sites that may
have been coincidentally introduced by the insertion pro-
cedure. Some corrections may not be possible, as in the
aforementioned incompatibility of a unique BssHII site with
AlaArgAla, or may produce a new undesired site. If a correc-
tion attempt fails, the software reports the error and its loca-
tion, chooses a new DNA sequence, re-initiates and completes
the design process. In case of failure in repeated automatic
design attempts, we encourage the user to remove the restric-
tion site that fails or reduce the number of restriction sites in
the list and try again. Also, with longer sequences a large
number of requested unique or undesirable sites may cause
repeated design failures that can be addressed by the reduction
of the sizes of the unique and/or desired sites lists.
Separation into synthons. The software proceeds to separate
the gene into synthons of specified size or number, or at the
user-designated restriction sites.
Oligonucleotide design. With the exception of the 50 oligos,
the upper and lower strand sequences of the synthons and
flanking sequences are used to design 40 nt oligos having
20 bp overlaps with each of two oligos of the opposite strand.
The 50 oligos are designed to be 20–40 bp to allow adjustment
for synthon length and are adjusted to keep them of similar
size. If connected, the oligos of the upper and lower strands
will usually exhibit short overhangs at each end. For example,
if a synthon and flanking sequences are 465 bp, the upper
strand might be composed of one 23mer and eleven
40mers, and the lower strand composed of a 50 22mer and
eleven 40mers; if connected, there would be a 3 nt overhang at
one end and a 2 nt overhang at the other.
The software then performs a specificity test to avoid
hybridization of any oligo component of the gene with inap-
propriate oligo components for PCR assembly. In the first
round of oligo extension each 40mer, the 30 20mers of the
40mer oligos are the productive primers in producing 60mers.
In the second round of extension, the productive primers are
the 30 20mers of the 60mers, equivalent to the 50 20mers of the
40mers. We, therefore, test all 20mers of the 40mers both 30
and 50 for primer specificity. Here, each 40 bp oligo of the
upper strand is split into two 20 bp half-oligos. The half-oligos
are screened against the length of the upper and lower synthon
strands. If a half-oligo has an exact match of a user-defined
length at the 30 end with any sequence other than the intended
one, and the half-oligo has user-defined unacceptable homo-
logy with that sequence, a failure in specificity is triggered; the
default values of the program are 3 bp at the 30 end and 70%
minimum homology. In certain cases, such as highly repetitive
amino acid sequences, passing the specificity test may require
decreasing the specificity threshold parameters.
A single half-oligo failure in specificity prompts the soft-
ware to add random base pairs, two at a time, at the edge of a
synthon sequence to allow further attempts to pass the speci-
ficity test. The addition of 2 bp of randomly picked sequence
at the 50 end, followed by reapplication of the algorithm has
the effect of moving all the inter-oligo junctions toward the
50 end by 1 bp. The change in junctions creates different oligo
sequences and boundaries, hence modifying the specificity
of half-oligos. After rechecking for half-oligo specificity,
the process is repeated until the specificity test is passed,
or the shifting junctions reach the initial junctions. If, for
example, the oligo length is 2L, where L is the half-oligo
length of 20, this allows up to 20 tries at passing the quality
control by using each codon-optimized DNA sequence con-
structed. If repair of the oligo specificity is not possible, entire
sets of synthon components of a sequence are automatically
recreated by using a new codon-optimized DNA sequence, and
specificity failures reported for each such attempt. The number
of attempts at making oligos that satisfy desired conditions is
preset by the user.
Tm and stem–loops. If the user chose to test the annealing
temperature of each half-oligo, and an oligo falls outside a
user-defined range, GeMS halts execution and reports a failed
Tm for the synthon with the number of oligos that failed. The
user may abort or accept one of the constructs.
Sequence reassembly and verifications. After all the synthons
of an entered sequence have passed the quality control tests,
they are reassembled to generate the larger DNA sequence.
The sequence is translated into protein and checked against the
original amino acid sequence for integrity. A final screen for
undesired sites is performed; if such sites are found, the user is
alerted and the program attempts a new run at designing the
sequence. Upon passing this final screen, the sequence and
corresponding oligo components to be used for synthesis are
stored.
Oligonucleotide components. The software assigns the collec-
tion of oligos needed for all of the synthons composing the
desired sequence to a series of 96-well plates. This information
is used to generate order sheets for gene synthesis and can
serve as instructions for the robot to select and combine the
appropriate oligo components of each synthon.
Gene design report
Upon activation, the program presents a summary report of the
design. The program reports whether a successful design was
achieved and, if so, the number of attempts made to achieve it.
If unsuccessful, we recommend more design attempts or
changes in parameters. Then, details of the sequence design
are presented, with hyperlinks that allow access to the final
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codon distribution, Tm of overlaps between pairs of oligos, the
designed DNA sequence and an alignment of the input versus
final protein sequence to allow visual verification. There are
two files that we recommend be opened and saved as perman-
ent records. The first contains all details of the gene design; the
second provides the oligo components in a spreadsheet that
can be used to order them and as an input to a robot for
automated gene synthesis. Finally, the report provides the
sequence of each synthon with and without primers attached,
the oligo components for each synthon and the complete
sequence of the assembled gene.
DISCUSSION
Here, we describe a user-friendly, advanced software package
for the design of synthetic genes. The software was developed
to design synthetic genes to be made by the PCR assembly of
short oligos, but it should be adaptable to ligation methods as
well (10–12). The user provides a protein or DNA sequence
and enters various parameters, and the software provides opti-
mized oligos for the synthesis of the designed genes. The
software contains most components found in other gene syn-
thesis programs (2–5), as well as certain unique features.
Some of the differentiating features of GeMS are as follows.
(i) GeMS offers automatic spacing or manual placement of
unique or redundant restriction sites along the gene sequence.
It will also prevent specified sites from occurring in the gene.
For restriction site placement, most programs back-translate
proteins into nucleotide sequences rather than into codons, and
then search the back-translated sequence for restriction sites;
as described in Results, this often generates phantom sites that
change the sequence of the encoded protein. By back-
translating amino acids into codons, GeMS avoids such phan-
tom restriction sites. (ii) A tool is provided that allows creation
of hybrid codon preference tables for optimizing gene expres-
sion in two or more organisms. (iii) If specified, the software
will automatically separate long coding sequences into smaller
fragments or synthons to be synthesized, which can be ligated
together. The user can choose to add adjacent Type IIs sites to
generate overlapping cohesive ends on adjacent synthons or to
separate synthons at unique restriction sites for conventional
ligations. In either case, the adjustments for design, such as
creating overlapping sites on adjacent synthons, are made
automatically. (iv) GeMS uses a unique algorithm to optimize
oligo components of the synthons so that they do not mis-
prime in PCR gene assembly. The combination of codon
randomization with the specificity-checking step prevents
the formation of most possible stem–loop structures, which
we rarely or never observe in genes designed with GeMS.
(v) GeMS calculates and reports, but does not adjust for,
Tm values of component oligos. Although some workers
have advocated this (2–4,13), we are unaware of objective
data supporting it, and our failure in synthon assembly by
PCR has thus far been negligible. Perhaps our algorithm for
avoiding oligo mispriming overcomes possible advantages of
iso-thermal Tm values.
To date, we have used GeMS to design over 400 kb of
synthetic genes ranging from 0.5 to >6 kb in length. Our
failure rate in synthesis has been negligible and we conclude
that the software is suitable for the design of most genes of
current interest.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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